Association for Molecular Pathology

Association for Molecular Pathology
Name	Association for Molecular Pathology
Founded	1995
Founder	William G. Coleman III; Dennis Lo
Headquarters	New York City
Location	United States
Focus	Molecular diagnostics; Clinical laboratory science

Association for Molecular Pathology is a professional society focused on molecular pathology and molecular diagnostics in clinical and research settings. It engages with stakeholders across biotechnology and pharmaceutical industry sectors, collaborates with academic centers, and participates in legal and regulatory matters affecting laboratory medicine. The organization interacts with government agencies, patient groups, and international bodies to advance standards for genetic testing, precision medicine, and genomic technologies.

History

The organization was established amid the expansion of Human Genome Project-era initiatives and the rise of polymerase chain reaction applications in clinical laboratories, paralleling efforts at National Institutes of Health, Centers for Disease Control and Prevention, and the Food and Drug Administration. Early leadership included clinicians and scientists from institutions such as Johns Hopkins University, Harvard Medical School, Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, and Mayo Clinic. The society engaged with litigation and policy debates exemplified by cases involving Association for Molecular Pathology v. Myriad Genetics, Inc. (linked controversies with Supreme Court of the United States decisions) and collaborated with consortia similar to Clinical Laboratory Improvement Amendments discussions and American College of Medical Genetics and Genomics working groups. Its timeline intersects with advancements at Cold Spring Harbor Laboratory, Broad Institute, Sanger Institute, and partnerships with international organizations such as European Society of Human Genetics and World Health Organization initiatives.

Mission and Activities

The group's mission aligns with objectives articulated by leaders at Genentech, Illumina, Thermo Fisher Scientific, and academic innovators at Stanford University School of Medicine and University of California, San Francisco. Activities include guideline development akin to publications by College of American Pathologists, participation in standard-setting analogous to Clinical and Laboratory Standards Institute, and collaborations with registries like ClinVar and projects resembling The Cancer Genome Atlas. It facilitates translational efforts with centers including Fred Hutchinson Cancer Research Center, Dana-Farber Cancer Institute, Children's Hospital of Philadelphia, and engages with advocacy organizations such as American Cancer Society and Susan G. Komen.

Membership and Governance

Membership comprises professionals from institutions like Columbia University Irving Medical Center, Yale School of Medicine, University of Pennsylvania Health System, Cleveland Clinic, and University of Chicago Medicine. Governance structures mirror boards at American Association for Cancer Research and American Society of Human Genetics, with committees reflecting expertise from European Molecular Biology Laboratory, National Cancer Institute, Stanford Cancer Institute, and representatives from companies like Roche and Agilent Technologies. Elected officers have affiliations with universities such as University of Michigan, University of Washington, Vanderbilt University Medical Center, and University of Texas MD Anderson Cancer Center.

Education and Certification

Educational programs include continuing education modeled after offerings by American Society of Clinical Oncology and American Board of Pathology, with workshops similar to those at Cold Spring Harbor Laboratory and training partnerships like Howard Hughes Medical Institute initiatives. Certification pathways and competency frameworks reference standards comparable to European Board of Medical Genetics, Royal College of Pathologists, and accreditation approaches used by Joint Commission. The society provides resources used by trainees at Massachusetts Institute of Technology, Princeton University, Cornell University, and postdoctoral fellows from Salk Institute for Biological Studies.

Policy and Advocacy

The organization advocates on policy issues intersecting with rulings by the Supreme Court of the United States, rulemaking at the Food and Drug Administration, reimbursement policies at the Centers for Medicare & Medicaid Services, and legislation in the United States Congress. It submits comments alongside groups such as American Medical Association, Patient-Centered Outcomes Research Institute, and National Organization for Rare Disorders; engages with international regulators like European Medicines Agency and participates in initiatives connected to Organisation for Economic Co-operation and Development health working groups.

Research and Publications

The society sponsors research collaborations that publish in journals akin to The New England Journal of Medicine, Nature Genetics, Science Translational Medicine, The Lancet Oncology, and JAMA. It issues practice guidelines and technical reports comparable to those from American Journal of Clinical Pathology and Genome Research, and supports data-sharing efforts with databases like dbGaP and networks similar to All of Us Research Program. Collaborators have ties to research centers such as Scripps Research, Baylor College of Medicine, Weill Cornell Medicine, and Rutgers University.

Awards and Conferences

Annual conferences bring together presenters from American Society of Clinical Pathology, International Society for Biological and Environmental Repositories, European Society for Medical Oncology, American Association for Cancer Research, and industry partners including Pfizer and Merck & Co.. Awards recognize achievements reminiscent of honors from Lasker Foundation, Breakthrough Prize, Gairdner Foundation, and institutional prizes at Rockefeller University and Cold Spring Harbor Laboratory. Meetings often feature keynote speakers from Nobel Prize in Physiology or Medicine laureates and leaders from Genomics England, 100,000 Genomes Project, and large-scale initiatives such as International Cancer Genome Consortium.

Category:Medical associations